A cosmetic medical device corporation, ASTERASYS, reported a consolidated revenue of 17 billion won and an operating profit of 4.4 billion won for the first half of this year on the 13th. This is an increase of 50% and 198%, respectively, compared to the same period last year. The company explained that this is the largest performance for the first half of the year since its establishment.
The treatment device CoolPhase has sold well overseas. CoolPhase delivers radio frequency energy to the skin. It safely protects the skin surface with a patented cooling method. CoolPhase is currently undergoing certification by the U.S. Food and Drug Administration (FDA).
The introduction of the device CoolSonic, which induces skin collagen regeneration, also impacted the results. With the increase in related procedures, the sales of consumables also rose. The company aims to target the overseas market.